Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839798 · ClinicalTrials.gov registry record · Phase 2
NeoSync TMS Treatment for Bipolar I Depression
A Phase 2 study, sponsored by Butler Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02839798 is a Phase 2 study that was terminated before completion, run by Butler Hospital. The registered enrollment target is 6 participants.
The verdict
NCT02839798, a Phase 2 study, was terminated before completion, sponsored by Butler Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and preliminary efficacy of synchronized transcranial magnetic stimulation (sTMS) using the NeoSync EEG Synchronized TMS device (NEST) in subjects with Bipolar Disorder type I in a Major Depressive Episode. This is an open label study in which subjects will receive treatment 5 days per week for 6 weeks.
Interventions
- DEVICE NEST (NeoSync EEG Synchronized TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-11-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02839798
The ClinicalTrials.gov registry entry for NCT02839798 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NEST (NeoSync EEG Synchronized TMS) is the first listed.
NCT02839798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02839798 about?
NCT02839798 is a clinical study titled "NeoSync TMS Treatment for Bipolar I Depression". This study is designed to evaluate the safety and preliminary efficacy of synchronized transcranial magnetic stimulation (sTMS) using the NeoSync EEG Synchronized TMS device (NEST) in subjects with Bipolar Disorder type I in a Major Depressive Episode. This is an open label study in which subjects w...
What is the current status of trial NCT02839798?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2016-05. Estimated completion is 2018-11-19.
What interventions are being tested in trial NCT02839798?
The interventions under investigation include: NEST (NeoSync EEG Synchronized TMS) (DEVICE).
Who is sponsoring clinical trial NCT02839798?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.